{
    "applicationNumber": "BR 11 2021 003916-3",
    "filingDate": "03/09/2019",
    "grantDate": null,
    "title": "MOL\u00c9CULA DE ANTICORPO, SEQU\u00caNCIA DE NUCLEOT\u00cdDEOS ISOLADA, PLASM\u00cdDEO, V\u00cdRUS, C\u00c9LULA, USO DE UMA MOL\u00c9CULA DE ANTICORPO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, E, M\u00c9TODO PARA TRATAR C\u00c2NCER EM UM SUJEITO",
    "nationalPhaseDate": [
        "01/03/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2019/073488",
        "pctDate": "03/09/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "18192311.1",
            "priorityDate": "03/09/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2618"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2629"
        }
    ],
    "inventors": [
        "BJ\u00d6RN FRENDEUS",
        "INGRID TEIGE",
        "MONIKA SEMMRICH",
        "LINDA M\u00c5RTENSSON",
        "PETRA HOLMKVIST",
        "BAPTISTE MARCHAND",
        "NATHALIE SILVESTRE"
    ],
    "holders": [
        80537,
        268753
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61P 37/02",
        "C07K 16/28"
    ]
}